Skip to content

Clinical trials

Terminated Phase 2 Hepatitis C trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 2 Status: Terminated Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20062
20072
20091
20102
20113
20123
20131
20152
20162
20182
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
Gilead Sciences2
MassBiologics2
Merck Sharp & Dohme LLC2
Novartis Pharmaceuticals2
ADMA Biologics, Inc.1
ANRS, Emerging Infectious Diseases1
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections1
Alexion Pharmaceuticals, Inc.1
Bausch Health Americas, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C24
Hepatitis3
Hepatitis C, Chronic3
HIV Infections2
Hepatitis, Chronic2
Virus Diseases2
Ascites1
Bronchiolitis Obliterans Syndrome1
Digestive System Diseases1
Esophageal and Gastric Varices1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.